Showing 1 - 9 results of 9 for search 'Mark Sculpher', query time: 0.05s
Refine Results
-
1
-
2
Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model by Clive Pritchard, Lucie Kutikova, Richard Pitman, Kira Zhi Hua Lai, Hadi Beyhaghi, IIana Gibbons, Amanda Erbe, Marija Živković-Gojović, Catherine Cosgrove, Mark Sculpher, David Salisbury
Published 2025-02-01
Article -
3
Cost-effectiveness analysis of acupuncture, counselling and usual care in treating patients with depression: the results of the ACUDep trial. by Eldon Spackman, Stewart Richmond, Mark Sculpher, Martin Bland, Stephen Brealey, Rhian Gabe, Ann Hopton, Ada Keding, Harriet Lansdown, Sara Perren, David Torgerson, Ian Watt, Hugh MacPherson
Published 2014-01-01
Article -
4
Developing a Modeling Framework for Quantifying the Health and Cost Implications of Antibiotic Resistance for Surgical Procedures by Heather Davies, Joel Russell, Angel Varghese, Hayden Holmes, Marta O. Soares, Beth Woods, Ruth Puig-Peiro, Stephanie Evans, Rory Tierney, Stuart Mealing, Mark Sculpher, Julie V. Robotham
Published 2023-02-01
Article -
5
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model by Beth Woods, Laetitia Schmitt, Dina Jankovic, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark Sculpher, Sue Harnan
Published 2024-06-01
Article -
6
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model by Sue Harnan, Ben Kearns, Alison Scope, Laetitia Schmitt, Dina Jankovic, Jean Hamilton, Tushar Srivastava, Harry Hill, Chu Chang Ku, Shijie Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods
Published 2024-10-01
Article -
7
A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in Malawi by Joseph Mfutso-Bengo, Faless Jeremiah, Florence Kasende-Chinguwo, Wingston Ng’ambi, Nthanda Nkungula, Isabel Kazanga-Chiumia, Mercy Juma, Marlen Chawani, Jobiba Chinkhumba, Pakwanja Twea, Emily Chirwa, Kate Langwe, Gerald Manthalu, Lucky Gift Ngwira, Dominic Nkhoma, Tim Colbourn, Paul Revill, Mark Sculpher
Published 2023-04-01
Article -
8
Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2 by Colin Berry, Simon Walker, Chiara Bucciarelli-Ducci, Sven Plein, Abhiram Prasad, Kenneth Mangion, Petra Bijsterveld, Catherine Reynolds, Catherine Fernandez, Julia Brown, Erica Dall’Armellina, Deborah Stocken, Mark Sculpher, Colin C. Everett, Gerry P. McCann, James R. Foley, John P. Greenwood
Published 2023-05-01
Article -
9
Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care... by Richard D Neal, Kevin Franks, David Torgerson, Rachael L Murray, David R Baldwin, Michael Darby, Henrik Moller, Richard Booton, Una MacLeod, Sam M Janes, Samantha L Quaife, Sebastian Hinde, Matthew EJ Callister, Suzanne Rogerson, Rhian Gabe, Mark Sculpher, Philip AJ Crosbie, Irene Simmonds, Martyn Kennedy, Nazia Ahmed, Ann Cochrane, Mike Messenger, Puvanendran Tharmanathan
Published 2020-09-01
Article